Mera Pharmaceuticals Inc (MRPI)

[HobbyTrader]

Mera Pharmaceuticals, Inc. MRPI
OTCQB / Common Stock

52wk Range0.01 - 0.002

Share Structure
Market Value1 $1,259,871 a/o Feb 01, 2011
Shares Outstanding 547,769,915 a/o Jul 31, 2010
Shares Authorized 750,000,000 a/o Jul 31, 2010

Contact Info
• 73-4460 Queen Ka'ahumanu Highway
• Suite 110
• Kailua-Kona, HI , 96740
• Website: http://www.merapharma.com
• Phone: [phone]
• Email: [e-mail]

Mera Pharmaceuticals, Inc., a marine biotechnology company, manufactures natural astaxanthin fromHaematococcus pluvialis microalgae. Mera's powerful astaxanthin supplement, AstaFactor, with strong antioxidant and anti-inflammatory activity, is available in three formulations:
• Rejuvenating Formula
• Sports Formula
• Salmon essentials - natural astaxanthin combined with a pure blend of fish and salmon oil
Mera Pharmaceuticals, Inc. is a global leader in photobioreactor technology and owns extensive intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production.
In addition, Mera Pharmaceuticals, Inc. produces a renowned sea salt, which continues to earn accolades from top executive chefs and fitness experts for its delicate flavor and rich trace mineral content. An exceptional sea salt, Kona Sea Salt originates in the pristine waters off the Island of Hawaii Kona Coast. Drawn from the depths of 2200 feet, this special water is warmed by the Hawaiian sun, and evaporates naturally in our unique, closed drying system.

Company Owns 3 Websites:
http://www.domaintools.com/reverse-ip/?hostname=merapharma.com

http://www.Astafactor.com
http://www.Konaseasalt.com
http://www.Merapharma.com

10-K late but due by Feb 15th:

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

Mera’s auditors were unable to schedule transportation to Hawaii in a timely manner in order to complete the company’s audit for the period ended October 31, 2010. It is expected that the audit will be filled by February 15, 2011.